News and Reports

Globe
  • Farmalatam Holding Inc. (Farmalisto) achieves investment of US $ 18 million from the IDB Invest, HBM Healthcare Investments Ltd. and Morgan Río Capital Management

    15 January 2021
    Download
  • IO Biotech Completes Oversubscribed EUR 127 Million Series B Financing to Accelerate Clinical Programs in Oncologypdf.

    13 January 2021
    Download
  • Valo Raises $190 Million in Series B Financing and Unveils Select Therapeutic Programs

    11 January 2021
    Download
  • VISEN Pharmaceuticals Closes $150 Million Series B Financing to Accelerate the Development and Commercialization of its Innovative Endocrinology Therapies in Greater China

    9 January 2021
    Download
  • Adrenomed Supervisory Board appoints Dr. Wolfgang Baiker as CEO

    4 January 2021
    Download
  • Y-MABS Therapeutics and Swixx Complete CEE & RUSSIA Deal on DANYELZA® and OMBURTAMAB

    18 December 2020
    Download
  • BioAtla Announces Pricing of Initial Public Offering

    15 December 2020
    Download
  • Nuance Pharma Closes Series D Financing

    8 December 2020
    Download
  • Seer Announces Pricing of Initial Public Offering

    4 December 2020
    Download
  • Adrenomed Closes EUR 22 Million Equity Financing to Accelerate Development of Adrecizumab (HAM8101) and Provides Business Update

    30 November 2020
    Download
  • FDA Approves Y-mAbs’ DANYELZA® (naxitamab-gqgk) for the Treatment of Neuroblastoma

    25 November 2020
    Download
  • Arcutis Announces Positive Topline Data from Phase 2b Study of ARQ-154 (Topical Roflumilast Foam) as a Potential Treatment for Scalp and Body Psoriasis

    23 November 2020
    Download
  • Enhancing Market Position in the Synthetic Biology Industry to Promote High End Biologically Manufactured Alternatives?A Dialogue with Cathay Biotech Inc. Chairman Liu Xiucai

    20 November 2020
    Download
  • ALX Oncology Announces New Data from ASPEN-01, the Phase 1b Study of ALX148, Showing Promising Initial Clinical Responses in Patients with Advanced Solid Tumors

    16 November 2020
    Download
  • Ambrx Closes $200 million in Crossover Financing with Leading Healthcare Investors to Advance its Clinical and Preclinical Pipeline of Precision Biologics

    9 November 2020
    Download
  • Galecto Announces Pricing of Initial Public Offering

    29 October 2020
    Download
  • Arena Pharmaceuticals Announces Launch of Longboard Pharmaceuticals With $56M Financing, Building a Novel Neuroscience Drug Development Company

    28 October 2020
    Download
  • Dren Bio Announces a $60M Series A Financing

    16 October 2020
    Download
  • Cathay Biotech to Invest USD596.5 Million in Northwest China's Largest Synthetic Biology Project

    12 October 2020
    Download
  • New CEO Joins Karius to Lead Next Growth Phase

    6 October 2020
    Download
  • Arcutis Announces Positive Topline Data from Phase 2 Clinical Trial Evaluating ARQ-154 (Topical Ro

    29 September 2020
    Download
  • Sanofi Completes Principia Biopharma Inc. Acquisition

    28 September 2020
    Download
  • BioShin, Biohaven's Asia-Pacific Subsidiary, Raises $60M in Series A Funding to Advance Neuroscience Pipeline in Asia-Pacific Region

    28 September 2020
    Download
  • Monte Rosa Therapeutics Announces $96 Million Series B Financing to Advance Small Molecule-based Protein Degradation Platform

    24 September 2020
    Download
  • Novellus Closes $57M Series C Financing

    21 September 2020
    Download